NCT03699774 - Effect of Repeated Doses of DS-8500a on Pharmacokinetics of Rosuvastatin in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 12, 2015

Primary Completion Date

July 6, 2015

Study Completion Date

July 6, 2015

Conditions

Drug Pharmacokinetics in Healthy Volunteers

Interventions

DRUG

DS-8500a

DS-8500a is provided as three 25-mg tablets for oral administration

DRUG

Rosuvastatin

Rosuvastatin is provided as a 10-mg tablet for oral administration

Trial Locations (1)

Worldwide Clinical Trials (WCT) Early Phase Services, San Antonio